HEADER LIGASE/ISOMERASE/PROTEIN BINDING 05-NOV-11 3UIP TITLE COMPLEX BETWEEN HUMAN RANGAP1-SUMO1, UBC9 AND THE IR1 DOMAIN FROM TITLE 2 RANBP2 CONTAINING IR2 MOTIF II COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUMO-CONJUGATING ENZYME UBC9; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SUMO-PROTEIN LIGASE, UBIQUITIN CARRIER PROTEIN 9, UBIQUITIN COMPND 5 CARRIER PROTEIN I, UBIQUITIN-CONJUGATING ENZYME E2 I, UBIQUITIN- COMPND 6 PROTEIN LIGASE I, P18; COMPND 7 EC: 6.3.2.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SMALL UBIQUITIN-RELATED MODIFIER 1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 18-97; COMPND 13 SYNONYM: SUMO-1, GAP-MODIFYING PROTEIN 1, GMP1, SMT3 HOMOLOG 3, COMPND 14 SENTRIN, UBIQUITIN-HOMOLOGY DOMAIN PROTEIN PIC1, UBIQUITIN-LIKE COMPND 15 PROTEIN SMT3C, SMT3C, UBIQUITIN-LIKE PROTEIN UBL1; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: RAN GTPASE-ACTIVATING PROTEIN 1; COMPND 19 CHAIN: C; COMPND 20 FRAGMENT: UNP RESIDUES 419-587; COMPND 21 SYNONYM: RANGAP1; COMPND 22 ENGINEERED: YES; COMPND 23 MOL_ID: 4; COMPND 24 MOLECULE: E3 SUMO-PROTEIN LIGASE RANBP2; COMPND 25 CHAIN: D; COMPND 26 FRAGMENT: UNP RESIDUES 2631-2695; COMPND 27 SYNONYM: 358 KDA NUCLEOPORIN, NUCLEAR PORE COMPLEX PROTEIN NUP358, COMPND 28 NUCLEOPORIN NUP358, RAN-BINDING PROTEIN 2, RANBP2, P270; COMPND 29 ENGINEERED: YES; COMPND 30 MUTATION: YES; COMPND 31 OTHER_DETAILS: MOTIF II OF RANBP2 IR1 WAS MUTATED TO IR2 MOTIF II. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UBC9, UBCE9, UBE2I; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: OK/SW-CL.43, SMT3C, SMT3H3, SUMO1, UBL1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: KIAA1835, RANGAP1, SD; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PSMT3; SOURCE 31 MOL_ID: 4; SOURCE 32 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 33 ORGANISM_COMMON: HUMAN; SOURCE 34 ORGANISM_TAXID: 9606; SOURCE 35 GENE: NUP358, RANBP2; SOURCE 36 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 37 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 38 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 39 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 40 EXPRESSION_SYSTEM_PLASMID: PSMT3 KEYWDS E3, LIGASE, SUMO, UBC9, RANBP2, NUCLEAR PORE COMPLEX, LIGASE- KEYWDS 2 ISOMERASE-PROTEIN BINDING COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.GAREAU,D.REVERTER,C.D.LIMA REVDAT 4 12-NOV-14 3UIP 1 HET HETATM HETNAM HETSYN REVDAT 3 26-JUN-13 3UIP 1 JRNL REVDAT 2 04-JAN-12 3UIP 1 JRNL REVDAT 1 28-DEC-11 3UIP 0 JRNL AUTH J.R.GAREAU,D.REVERTER,C.D.LIMA JRNL TITL DETERMINANTS OF SMALL UBIQUITIN-LIKE MODIFIER 1 (SUMO1) JRNL TITL 2 PROTEIN SPECIFICITY, E3 LIGASE, AND SUMO-RANGAP1 BINDING JRNL TITL 3 ACTIVITIES OF NUCLEOPORIN RANBP2. JRNL REF J.BIOL.CHEM. V. 287 4740 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22194619 JRNL DOI 10.1074/JBC.M111.321141 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.2_869) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 38956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1949 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.9816 - 5.5199 0.98 2787 131 0.1931 0.2107 REMARK 3 2 5.5199 - 4.3842 0.99 2692 137 0.1596 0.1847 REMARK 3 3 4.3842 - 3.8309 1.00 2684 141 0.1590 0.1758 REMARK 3 4 3.8309 - 3.4810 1.00 2663 134 0.1799 0.2418 REMARK 3 5 3.4810 - 3.2317 1.00 2678 124 0.1985 0.2347 REMARK 3 6 3.2317 - 3.0413 1.00 2632 144 0.1954 0.2389 REMARK 3 7 3.0413 - 2.8891 1.00 2631 147 0.2090 0.2489 REMARK 3 8 2.8891 - 2.7634 1.00 2654 145 0.2099 0.2999 REMARK 3 9 2.7634 - 2.6570 1.00 2609 152 0.2143 0.2521 REMARK 3 10 2.6570 - 2.5654 1.00 2645 129 0.2167 0.3039 REMARK 3 11 2.5654 - 2.4852 1.00 2617 137 0.2160 0.2674 REMARK 3 12 2.4852 - 2.4142 1.00 2610 158 0.2089 0.2780 REMARK 3 13 2.4142 - 2.3506 0.99 2597 132 0.2218 0.2430 REMARK 3 14 2.3506 - 2.2930 0.95 2508 138 0.2465 0.3013 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 36.95 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.690 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.28050 REMARK 3 B22 (A**2) : -1.58750 REMARK 3 B33 (A**2) : 8.86800 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3693 REMARK 3 ANGLE : 1.193 4995 REMARK 3 CHIRALITY : 0.081 553 REMARK 3 PLANARITY : 0.006 643 REMARK 3 DIHEDRAL : 16.099 1411 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3UIP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-11. REMARK 100 THE RCSB ID CODE IS RCSB068804. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38980 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.293 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.29400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1Z5S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG4000, 100 MM HEPES PH 7.5, 400 REMARK 280 MM AMMONIUM CITRATE, 2% ISOPROPANOL, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.70550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.70550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 68.32550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 99.59350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 68.32550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 99.59350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.70550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 68.32550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 99.59350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.70550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 68.32550 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 99.59350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 317 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 318 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU B 18 REMARK 465 GLY B 19 REMARK 465 SER C 417 REMARK 465 LEU C 418 REMARK 465 THR C 419 REMARK 465 GLY C 420 REMARK 465 GLU C 421 REMARK 465 PRO C 422 REMARK 465 ALA C 423 REMARK 465 PRO C 424 REMARK 465 VAL C 425 REMARK 465 LEU C 426 REMARK 465 SER C 427 REMARK 465 SER C 428 REMARK 465 PRO C 429 REMARK 465 PRO C 430 REMARK 465 PRO C 431 REMARK 465 SER D 2629 REMARK 465 ASP D 2691 REMARK 465 GLY D 2692 REMARK 465 SER D 2693 REMARK 465 GLU D 2694 REMARK 465 LYS D 2695 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C GLY B 97 NZ LYS C 524 1.32 REMARK 500 O HOH C 674 O HOH C 706 2.11 REMARK 500 OH TYR B 21 O LEU D 2630 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 83 137.10 179.93 REMARK 500 LYS A 101 -141.57 -139.64 REMARK 500 SER B 31 -7.57 83.55 REMARK 500 ARG D2663 158.13 175.15 REMARK 500 VAL D2667 -77.14 -86.92 REMARK 500 SER D2668 178.25 170.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z5S RELATED DB: PDB REMARK 900 RELATED ID: 3UIO RELATED DB: PDB REMARK 900 RELATED ID: 3UIN RELATED DB: PDB DBREF 3UIP A 1 158 UNP P63279 UBC9_HUMAN 1 158 DBREF 3UIP B 18 97 UNP P63165 SUMO1_HUMAN 18 97 DBREF 3UIP C 419 587 UNP P46060 RAGP1_HUMAN 419 587 DBREF 3UIP D 2631 2695 UNP P49792 RBP2_HUMAN 2631 2695 SEQADV 3UIP SER C 417 UNP P46060 EXPRESSION TAG SEQADV 3UIP LEU C 418 UNP P46060 EXPRESSION TAG SEQADV 3UIP SER D 2629 UNP P49792 EXPRESSION TAG SEQADV 3UIP LEU D 2630 UNP P49792 EXPRESSION TAG SEQADV 3UIP VAL D 2642 UNP P49792 ALA 2642 ENGINEERED MUTATION SEQADV 3UIP GLU D 2644 UNP P49792 GLN 2644 ENGINEERED MUTATION SEQADV 3UIP LYS D 2647 UNP P49792 LEU 2647 ENGINEERED MUTATION SEQADV 3UIP ASP D 2649 UNP P49792 THR 2649 ENGINEERED MUTATION SEQADV 3UIP THR D 2650 UNP P49792 LYS 2650 ENGINEERED MUTATION SEQRES 1 A 158 MET SER GLY ILE ALA LEU SER ARG LEU ALA GLN GLU ARG SEQRES 2 A 158 LYS ALA TRP ARG LYS ASP HIS PRO PHE GLY PHE VAL ALA SEQRES 3 A 158 VAL PRO THR LYS ASN PRO ASP GLY THR MET ASN LEU MET SEQRES 4 A 158 ASN TRP GLU CYS ALA ILE PRO GLY LYS LYS GLY THR PRO SEQRES 5 A 158 TRP GLU GLY GLY LEU PHE LYS LEU ARG MET LEU PHE LYS SEQRES 6 A 158 ASP ASP TYR PRO SER SER PRO PRO LYS CYS LYS PHE GLU SEQRES 7 A 158 PRO PRO LEU PHE HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 A 158 VAL CSD LEU SER ILE LEU GLU GLU ASP LYS ASP TRP ARG SEQRES 9 A 158 PRO ALA ILE THR ILE LYS GLN ILE LEU LEU GLY ILE GLN SEQRES 10 A 158 GLU LEU LEU ASN GLU PRO ASN ILE GLN ASP PRO ALA GLN SEQRES 11 A 158 ALA GLU ALA TYR THR ILE TYR CME GLN ASN ARG VAL GLU SEQRES 12 A 158 TYR GLU LYS ARG VAL ARG ALA GLN ALA LYS LYS PHE ALA SEQRES 13 A 158 PRO SER SEQRES 1 B 80 GLU GLY GLU TYR ILE LYS LEU LYS VAL ILE GLY GLN ASP SEQRES 2 B 80 SER SER GLU ILE HIS PHE LYS VAL LYS MET THR THR HIS SEQRES 3 B 80 LEU LYS LYS LEU LYS GLU SER TYR CYS GLN ARG GLN GLY SEQRES 4 B 80 VAL PRO MET ASN SER LEU ARG PHE LEU PHE GLU GLY GLN SEQRES 5 B 80 ARG ILE ALA ASP ASN HIS THR PRO LYS GLU LEU GLY MET SEQRES 6 B 80 GLU GLU GLU ASP VAL ILE GLU VAL TYR GLN GLU GLN THR SEQRES 7 B 80 GLY GLY SEQRES 1 C 171 SER LEU THR GLY GLU PRO ALA PRO VAL LEU SER SER PRO SEQRES 2 C 171 PRO PRO ALA ASP VAL SER THR PHE LEU ALA PHE PRO SER SEQRES 3 C 171 PRO GLU LYS LEU LEU ARG LEU GLY PRO LYS SER SER VAL SEQRES 4 C 171 LEU ILE ALA GLN GLN THR ASP THR SER ASP PRO GLU LYS SEQRES 5 C 171 VAL VAL SER ALA PHE LEU LYS VAL SER SER VAL PHE LYS SEQRES 6 C 171 ASP GLU ALA THR VAL ARG MET ALA VAL GLN ASP ALA VAL SEQRES 7 C 171 ASP ALA LEU MET GLN LYS ALA PHE ASN SER SER SER PHE SEQRES 8 C 171 ASN SER ASN THR PHE LEU THR ARG LEU LEU VAL HIS MET SEQRES 9 C 171 GLY LEU LEU LYS SER GLU ASP LYS VAL LYS ALA ILE ALA SEQRES 10 C 171 ASN LEU TYR GLY PRO LEU MET ALA LEU ASN HIS MET VAL SEQRES 11 C 171 GLN GLN ASP TYR PHE PRO LYS ALA LEU ALA PRO LEU LEU SEQRES 12 C 171 LEU ALA PHE VAL THR LYS PRO ASN SER ALA LEU GLU SER SEQRES 13 C 171 CYS SER PHE ALA ARG HIS SER LEU LEU GLN THR LEU TYR SEQRES 14 C 171 LYS VAL SEQRES 1 D 67 SER LEU ASP VAL LEU ILE VAL TYR GLU LEU THR PRO THR SEQRES 2 D 67 VAL GLU GLU LYS ALA LYS ALA ASP THR LEU LYS LEU PRO SEQRES 3 D 67 PRO THR PHE PHE CME TYR LYS ASN ARG PRO ASP TYR VAL SEQRES 4 D 67 SER GLU GLU GLU GLU ASP ASP GLU ASP PHE GLU THR ALA SEQRES 5 D 67 VAL LYS LYS LEU ASN GLY LYS LEU TYR LEU ASP GLY SER SEQRES 6 D 67 GLU LYS MODRES 3UIP CSD A 93 CYS 3-SULFINOALANINE MODRES 3UIP CME A 138 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3UIP CME D 2659 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CSD A 93 8 HET CME A 138 10 HET CME D2659 10 HETNAM CSD 3-SULFINOALANINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 5 HOH *343(H2 O) HELIX 1 1 ILE A 4 ASP A 19 1 16 HELIX 2 2 LEU A 94 GLU A 98 5 5 HELIX 3 3 THR A 108 GLU A 122 1 15 HELIX 4 4 GLN A 130 ASN A 140 1 11 HELIX 5 5 ASN A 140 PHE A 155 1 16 HELIX 6 6 LEU B 44 GLY B 56 1 13 HELIX 7 7 PRO B 58 ASN B 60 5 3 HELIX 8 8 THR B 76 GLY B 81 1 6 HELIX 9 9 ASP C 433 PHE C 440 1 8 HELIX 10 10 SER C 442 LEU C 449 1 8 HELIX 11 11 LYS C 452 THR C 461 1 10 HELIX 12 12 ASP C 465 SER C 478 1 14 HELIX 13 13 GLU C 483 ASN C 503 1 21 HELIX 14 14 ASN C 508 MET C 520 1 13 HELIX 15 15 LEU C 535 VAL C 546 1 12 HELIX 16 16 PRO C 552 ALA C 554 5 3 HELIX 17 17 LEU C 555 LYS C 565 1 11 HELIX 18 18 ASN C 567 CYS C 573 1 7 HELIX 19 19 CYS C 573 LYS C 586 1 14 HELIX 20 20 THR D 2641 LEU D 2651 1 11 HELIX 21 21 THR D 2656 ASN D 2662 5 7 HELIX 22 22 ASP D 2676 LYS D 2683 1 8 SHEET 1 A 4 VAL A 25 LYS A 30 0 SHEET 2 A 4 MET A 36 PRO A 46 -1 O ASN A 37 N THR A 29 SHEET 3 A 4 LEU A 57 LEU A 63 -1 O LEU A 60 N CYS A 43 SHEET 4 A 4 LYS A 74 PHE A 77 -1 O LYS A 76 N ARG A 61 SHEET 1 B 6 GLN B 69 ARG B 70 0 SHEET 2 B 6 LEU B 62 PHE B 66 -1 N PHE B 66 O GLN B 69 SHEET 3 B 6 VAL B 87 GLN B 92 -1 O GLU B 89 N LEU B 65 SHEET 4 B 6 TYR B 21 GLY B 28 1 N LYS B 25 O ILE B 88 SHEET 5 B 6 GLU B 33 LYS B 39 -1 O VAL B 38 N ILE B 22 SHEET 6 B 6 VAL D2632 GLU D2637 -1 O LEU D2633 N LYS B 37 LINK C VAL A 92 N CSD A 93 1555 1555 1.34 LINK C CSD A 93 N LEU A 94 1555 1555 1.33 LINK C TYR A 137 N CME A 138 1555 1555 1.33 LINK C CME A 138 N GLN A 139 1555 1555 1.33 LINK C PHE D2658 N CME D2659 1555 1555 1.33 LINK C CME D2659 N TYR D2660 1555 1555 1.33 CISPEP 1 SER A 2 GLY A 3 0 -2.88 CISPEP 2 TYR A 68 PRO A 69 0 -1.86 CISPEP 3 GLU A 78 PRO A 79 0 2.27 CISPEP 4 GLU D 2669 GLU D 2670 0 15.01 CRYST1 136.651 199.187 63.411 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007318 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005020 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015770 0.00000 MASTER 298 0 3 22 10 0 0 6 0 0 0 40 END